Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

China · Delayed Price · Currency is CNY

3.410

+0.030 (0.89%)

Jul 30, 2026, 3:00 PM CST

SHA:600381 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	303.67	343.42	270.26	213.88	160.18	127.76
Revenue Growth	12.75%	27.07%	26.36%	33.52%	25.37%	2.81%
Gross Profit	96.83	131.35	66.77	127.61	21.68	-20.02
Operating Income	-40	-17.6	-156.39	-119.2	-207.75	-209.89
Net Income	-62.51	-37.32	-198.77	-267.87	-287.55	-248.61
Earnings Per Share	-0.12	-0.07	-0.34	-0.46	-0.49	-0.42
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Advertising Agency	14.26
Inter-Segment Elimination	-67.8
Big Health Business	223.44
Fast Selling Drinks	173.52
Total	343.42

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	163.54	167.11	207.96	172.93	170.98	199.59
Total Debt	2.61	2.97	11.8	18.66	4.9	1.13
Net Cash (Debt)	160.93	164.15	196.16	154.27	166.09	198.46
Net Cash Growth	38.59%	-16.32%	27.15%	-7.11%	-16.31%	-6.61%
Net Cash Per Share	0.30	0.31	0.34	0.26	0.28	0.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	33.11	-26.41	80.97	23.92	-31.82	-63.93
Capital Expenditures	-6.67	-6.55	-4.93	-13.53	-0.82	-121.79
Free Cash Flow	26.44	-32.96	76.04	10.39	-32.64	-185.73
Free Cash Flow Growth	-	-	632.22%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	31.89%	38.25%	24.71%	59.67%	13.53%	-15.67%
Operating Margin	-13.17%	-5.13%	-57.86%	-55.73%	-129.70%	-164.28%
Pretax Margin	-15.47%	-7.28%	-74.45%	-121.70%	-184.34%	-197.60%
Profit Margin	-20.59%	-10.87%	-73.55%	-125.24%	-179.52%	-194.59%
FCF Margin	8.71%	-9.60%	28.14%	4.86%	-20.38%	-145.37%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	14.24	14.24	14.24	14.24	14.24
P/FCF Ratio	73.82	-	27.47	436.96	-	-
PS Ratio	6.43	7.38	7.73	21.22	45.12	38.74